Evidence map›Paper›PMID 17443399›Full record

ReviewPharmaceutical research2007

Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.

Leena N Patel, Jennica L Zaro, Wei-Chiang Shen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pharmaceutical research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Peptide cargo administration: current state and applications.Applied microbiology and biotechnology · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators.International journal of molecular sciences · 2022
    Article
  17. Poly-L-Arginine Molecule Properties in Simple Electrolytes: Molecular Dynamic Modeling and Experiments.International journal of environmental research and public health · 2022
    Article
  18. Review
  19. Review
  20. Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Leena N PatelDepartment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California 90089, USA.
Jennica L Zaro
Wei-Chiang Shen

Funding

ABSORPTION MECHANISMS FOR PEPTIDE/PROTEIN DRUGS VIA LUNGR01HL064365 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CRANDALL, EDWARD DAVID · 1999 to 2008
$6.3M
Membrane Transduction Peptides for Drug DeliveryR01GM070777 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SHEN, WEI-CHIANG · 2005 to 2008
$1.0M
NHLBI NIH HHS HL64365NIGMS NIH HHS GM070777
6 · The paper itself

Abstract

Cell penetrating peptides, generally categorized as amphipathic or cationic depending on their sequence, are increasingly drawing attention as a non-invasive delivery technology for macromolecules. Delivery of a diverse set of cargo in terms of size and nature ranging from small molecules to particulate cargo has been attempted using different types of cell penetrating peptides (CPPs) in vitro and in vivo. However, the internalization mechanism of CPPs is an unresolved issue to date, with dramatic changes in view regarding the involvement of endocytosis as a pathway of internalization. A key reason for the lack of consensus on the mechanism can be attributed to the methodology in deciphering the internalization mechanism. In this review, we highlight some of the methodology concerns, focus more on the internalization pathway and also provide a novel perspective about the intracellular processing of CPPs, which is a crucial aspect to consider when selecting a cell penetrating peptide as a drug delivery system. In addition, recent applications of cell penetrating peptides for the delivery of small molecules, peptides, proteins, oligonucleotides, nanoparticles and liposomes have been reviewed.

Indexed as

Drug CarriersActive Transport, Cell NucleusAmino Acid SequenceCell MembraneCell Membrane PermeabilityDrug Delivery SystemsEndocytosisEndosomesLiposomesMolecular Sequence DataNanoparticlesPeptidesDrug CarriersLiposomesPeptides

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.